Wilson Sonsini Goodrich & Rosati is pleased to sponsor LaunchBio’s Larger Than Life Science: The Future is Here. The convergence of artificial intelligence, big data, and the life sciences is changing everything. Drug discovery, clinical trials, patient monitoring, and even fitness are being redefined by AI and big data by offering faster, more precise, and comprehensible results that improve patient health. Many companies are now integrating these large data sets as part of the decision-making process.
Lori Doyle
ldoyle@wsgr.com
Megan Baier is chief executive officer of Wilson Sonsini and a member of the firm’s board of directors. As CEO, she is responsible for firm strategy, culture, and talent, and leads the day-to-day management of the firm’s business performance, including its operations, financial results, growth, AI and innovation, and risk management.
Megan has spent her career advising founders, boards, and public companies through the moments that define them: first financings, public offerings, and the governance decisions that follow. As a member of Wilson Sonsini's New York corporate group, she combines deep technical command of securities law with the judgment and steadiness clients need when the stakes are high.